APA (7th ed.) Citation

Yoshinaga, A., Kitamoto, K., Aoki, S., Terao, R., Inoue, T., Obata, R., & Azuma, K. (2025). Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance. PLoS ONE, 20(11), 1. https://doi.org/10.1371/journal.pone.0326018

Chicago Style (17th ed.) Citation

Yoshinaga, Akie, Kohdai Kitamoto, Shuichiro Aoki, Ryo Terao, Tatsuya Inoue, Ryo Obata, and Keiko Azuma. "Predictive Factors for the Efficacy of Brolucizumab in Refractory Polypoidal Choroidal Vasculopathy Following Aflibercept Resistance." PLoS ONE 20, no. 11 (2025): 1. https://doi.org/10.1371/journal.pone.0326018.

MLA (9th ed.) Citation

Yoshinaga, Akie, et al. "Predictive Factors for the Efficacy of Brolucizumab in Refractory Polypoidal Choroidal Vasculopathy Following Aflibercept Resistance." PLoS ONE, vol. 20, no. 11, 2025, p. 1, https://doi.org/10.1371/journal.pone.0326018.